Literature DB >> 22940073

Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z.

Jeffrey K Huang1, Carina C Ferrari, Glaucia Monteiro de Castro, David Lafont, Chao Zhao, Paola Zaratin, Sandrine Pouly, Beatrice Greco, Robin J M Franklin.   

Abstract

Protein tyrosine phosphatase receptor type Z (Ptprz) is widely expressed in the mammalian central nervous system and has been suggested to regulate oligodendrocyte survival and differentiation. We investigated the role of Ptprz in oligodendrocyte remyelination after acute, toxin-induced demyelination in Ptprz null mice. We found neither obvious impairment in the recruitment of oligodendrocyte precursor cells, astrocytes, or reactive microglia/macrophage to lesions nor a failure for oligodendrocyte precursor cells to differentiate and remyelinate axons at the lesions. However, we observed an unexpected increase in the number of dystrophic axons by 3 days after demyelination, followed by prominent Wallerian degeneration by 21 days in the Ptprz-deficient mice. Moreover, quantitative gait analysis revealed a deficit of locomotor behavior in the mutant mice, suggesting increased vulnerability to axonal injury. We propose that Ptprz is necessary to maintain central nervous system axonal integrity in a demyelinating environment and may be an important target of axonal protection in inflammatory demyelinating diseases, such as multiple sclerosis and periventricular leukomalacia.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940073      PMCID: PMC3483537          DOI: 10.1016/j.ajpath.2012.07.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  A peptide zipcode sufficient for anterograde transport within amyloid precursor protein.

Authors:  Prasanna Satpute-Krishnan; Joseph A DeGiorgis; Michael P Conley; Marcus Jang; Elaine L Bearer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

2.  Comparison of RPTP zeta/beta, phosphacan, and trkB mRNA expression in the developing and adult rat nervous system and induction of RPTP zeta/beta and phosphacan mRNA following brain injury.

Authors:  S E Snyder; J Li; P E Schauwecker; T H McNeill; S R Salton
Journal:  Brain Res Mol Brain Res       Date:  1996-08

3.  Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation.

Authors:  Claudia Patrignani; David T Lafont; Valeria Muzio; Béatrice Gréco; Rob Hooft van Huijsduijnen; Paola F Zaratin
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

Review 4.  Remyelination in experimental models of toxin-induced demyelination.

Authors:  W F Blakemore; R J M Franklin
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

5.  Differential expression of phosphacan/RPTPbeta isoforms in the developing mouse visual system.

Authors:  Alice Klausmeyer; Jeremy Garwood; Andreas Faissner
Journal:  J Comp Neurol       Date:  2007-10-20       Impact factor: 3.215

6.  Receptor-like protein tyrosine phosphatase zeta/RPTP beta is expressed on tangentially aligned neurons in early mouse neocortex.

Authors:  Kyoji Ohyama; Emi Ikeda; Koki Kawamura; Nobuaki Maeda; Masaharu Noda
Journal:  Brain Res Dev Brain Res       Date:  2004-01-31

7.  Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia.

Authors:  Alexandre Dobbertin; Kate E Rhodes; Jeremy Garwood; Francesca Properzi; Nicolas Heck; John H Rogers; James W Fawcett; Andreas Faissner
Journal:  Mol Cell Neurosci       Date:  2003-12       Impact factor: 4.314

Review 8.  Multiple sclerosis: an immune or neurodegenerative disorder?

Authors:  Bruce D Trapp; Klaus-Armin Nave
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 9.  Receptor protein tyrosine phosphatases in nervous system development.

Authors:  Karl G Johnson; David Van Vactor
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

10.  Retinoid X receptor gamma signaling accelerates CNS remyelination.

Authors:  Jeffrey K Huang; Andrew A Jarjour; Brahim Nait Oumesmar; Christophe Kerninon; Anna Williams; Wojciech Krezel; Hiroyuki Kagechika; Julien Bauer; Chao Zhao; Anne Baron-Van Evercooren; Pierre Chambon; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Nat Neurosci       Date:  2010-12-05       Impact factor: 24.884

View more
  10 in total

1.  Harnessing the Benefits of Neuroinflammation: Generation of Macrophages/Microglia with Prominent Remyelinating Properties.

Authors:  Manoj Kumar Mishra; Khalil S Rawji; Michael B Keough; Janson Kappen; Reza Dowlatabadi; Hans J Vogel; Sameeksha Chopra; Félix Distéfano-Gagné; Antoine Dufour; David Gosselin; V Wee Yong
Journal:  J Neurosci       Date:  2021-03-12       Impact factor: 6.167

2.  Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.

Authors:  Nathan J Michaels; Kennedy Lemmon; Jason R Plemel; Samuel K Jensen; Manoj K Mishra; Dennis Brown; Khalil S Rawji; Marcus Koch; V Wee Yong
Journal:  J Neurosci       Date:  2020-10-15       Impact factor: 6.167

3.  1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation.

Authors:  Hasti Atashi Shirazi; Javad Rasouli; Bogoljub Ciric; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Exp Mol Pathol       Date:  2015-02-11       Impact factor: 3.362

4.  Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

Authors:  Oscar G Vidaurre; Jeffery D Haines; Ilana Katz Sand; Kadidia P Adula; Jimmy L Huynh; Corey A McGraw; Fan Zhang; Merina Varghese; Elias Sotirchos; Pavan Bhargava; Veera Venkata Ratnam Bandaru; Giulio Pasinetti; Weijia Zhang; Matilde Inglese; Peter A Calabresi; Gang Wu; Aaron E Miller; Norman J Haughey; Fred D Lublin; Patrizia Casaccia
Journal:  Brain       Date:  2014-06-03       Impact factor: 13.501

5.  Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.

Authors:  Norah Hibbits; Jun Yoshino; Tuan Q Le; Regina C Armstrong
Journal:  ASN Neuro       Date:  2012-10-30       Impact factor: 4.146

6.  Cell Densities in the Mouse Brain: A Systematic Review.

Authors:  Daniel Keller; Csaba Erö; Henry Markram
Journal:  Front Neuroanat       Date:  2018-10-23       Impact factor: 3.856

7.  Behavioral and neurological analyses of adult mice carrying null and distinct loss-of-receptor function mutations in protein tyrosine phosphatase receptor type Z (PTPRZ).

Authors:  Naomi Tanga; Kazuya Kuboyama; Ayako Kishimoto; Miho Kihara; Hiroshi Kiyonari; Toshio Watanabe; Akihiro Fujikawa; Masaharu Noda
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

8.  Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish.

Authors:  Stamatiki Katraki-Pavlou; Pinelopi Kastana; Dimitris Bousis; Despoina Ntenekou; Aimilia Varela; Constantinos H Davos; Sophia Nikou; Eleni Papadaki; Grigorios Tsigkas; Emmanouil Athanasiadis; Gonzalo Herradon; Constantinos M Mikelis; Dimitris Beis; Evangelia Papadimitriou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-12       Impact factor: 5.125

9.  Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.

Authors:  Bernardino Ossola; Chao Zhao; Alastair Compston; Stefano Pluchino; Robin J M Franklin; Maria Grazia Spillantini
Journal:  Glia       Date:  2015-11-18       Impact factor: 7.452

10.  Role of RPTPβ/ζ in neuroinflammation and microglia-neuron communication.

Authors:  Rosalía Fernández-Calle; Milagros Galán-Llario; Esther Gramage; Begoña Zapatería; Marta Vicente-Rodríguez; José M Zapico; Beatriz de Pascual-Teresa; Ana Ramos; M Pilar Ramos-Álvarez; María Uribarri; Marcel Ferrer-Alcón; Gonzalo Herradón
Journal:  Sci Rep       Date:  2020-11-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.